[HTML][HTML] LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axis

TR Cimato, BA Palka, JK Lang, RF Young - PLoS One, 2013 - journals.plos.org
TR Cimato, BA Palka, JK Lang, RF Young
PLoS One, 2013journals.plos.org
Background Hypercholesterolemia plays a critical role in atherosclerosis. CD34+ CD45dim
Lineage-hematopoietic stem/progenitor cells (HSPCs) give rise to the inflammatory cells
linked to atherosclerosis. In mice, high cholesterol levels mobilize HSPCs into the
bloodstream, and promote their differentiation to granulocytes and monocytes. The objective
of our study was to determine how cholesterol levels affect HSPC quantity in humans.
Methods We performed a blinded, randomized hypothesis generating study in human …
Background
Hypercholesterolemia plays a critical role in atherosclerosis. CD34+ CD45dim Lineage- hematopoietic stem/progenitor cells (HSPCs) give rise to the inflammatory cells linked to atherosclerosis. In mice, high cholesterol levels mobilize HSPCs into the bloodstream, and promote their differentiation to granulocytes and monocytes. The objective of our study was to determine how cholesterol levels affect HSPC quantity in humans.
Methods
We performed a blinded, randomized hypothesis generating study in human subjects (n=12) treated sequentially with statins of differing potencies to vary lipid levels. CD34+ HSPC levels in blood were measured by flow cytometry. Hematopoietic colony forming assays confirmed the CD34+ population studied as HSPCs with multlineage differentiation potential. Mobilizing cytokine levels were measured by ELISA.
Results
The quantity of HSPCs was 0.15 ± 0.1% of buffy coat leukocytes. We found a weak, positive correlation between CD34+ HSPCs and both total and LDL cholesterol levels (r2=0.096, p < 0.025). Additionally, we tested whether cholesterol modulates CD34+ HSPCs through direct effects or on the levels of mobilizing cytokines. LDL cholesterol increased cell surface expression of CXCR4, G-CSFR affecting HSPC migration, and CD47 mediating protection from phagocytosis by immune cells. LDL cholesterol also increased proliferation of CD34+ HSPCs (28 ± 5.7%, n=6, p < 0.03). Finally, the HSPC mobilizing cytokine G-CSF (r2=0.0683, p < 0.05), and its upstream regulator IL-17 (r2=0.0891, p < 0.05) both correlated positively with LDL cholesterol, while SDF-1 levels were not significantly affected.
Conclusions
Our findings support a model where LDL cholesterol levels positively correlate with CD34+ HSPC levels in humans through effects on the levels of G-CSF via IL-17 promoting mobilization of HSPCs, and by direct effects of LDL cholesterol on HSPC proliferation. The findings are provocative of further study to determine if HSPCs, like cholesterol levels, are linked to CVD events.
PLOS